Status:

COMPLETED

Bone Marrow Mesenchymal Stem Cells Transfer in Patients With ST-segment Elevation Myocardial Infarction

Lead Sponsor:

Affiliated Hospital of North Sichuan Medical College

Collaborating Sponsors:

Chinese PLA General Hospital

Peking Union Medical College Hospital

Conditions:

Myocardial Infarction

Eligibility:

All Genders

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

To investigate the effect and safety of intracoronary autologous bone morrow mesenchymal stem cells (BM-MSCs) transplantation in patients with ST-segment elevation myocardial infarction( STEMI) .

Detailed Description

To investigate the safety of intra-coronary injection of autologous bone marrow mesenchymal stem cells (BM-MSCs) in patients with ST-segment elevation myocardial infarction and its effect on cardiac f...

Eligibility Criteria

Inclusion

  • Age\> 18 years old;
  • Diagnosed acute ST-elevation myocardial infarction (STEMI)
  • STEMI onset \<1 month
  • Successful vascular remodeling, blood flow of infarct-related blood vessels recovered to TIMI level 3
  • All patients included in the study signed an informed consent form and promised to complete all follow-up plans

Exclusion

  • Refractory persistent ventricular tachycardia
  • High cardiac block and no pacemaker control
  • Liver or renal dysfunction (ALT\>80U/ L, Cr\> 440mmol / L)
  • Bleeding disorders, malignant tumors
  • Autoimmune disease or any serious fatal disease
  • Contraindications for coronary intervention
  • Combined with other heart disease: congenital heart Disease (ventricular deficiency, atrial deficient, patent ductus arteriosus and other congenital alformations),primary valvular disease, active myocarditis, pulmonary heart disease,hyperthyroidism, mucous edema heart disease and so on
  • Mental illness, no self-awareness, and no precise expression and cooperation

Key Trial Info

Start Date :

May 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 15 2011

Estimated Enrollment :

43 Patients enrolled

Trial Details

Trial ID

NCT04421274

Start Date

May 1 2008

End Date

July 15 2011

Last Update

June 9 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The Third Hospital of Mianyang

Mianyang, Sichuan, China, 0816